Johnson & Johnson said on Monday it has discontinued a late-stage study testing its experimental drug to treat a type of ...

Dozens of over-the-counter acne products had very high levels of the known carcinogen benzene, even when they were taken ...

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

Researchers in China are testing an experimental 3D-printed breast prosthesis that can sense and target breast cancer relapse, according to a report in Advanced Science.

Study addresses long-standing debate on pros ... 2024 GSK to Seek Dismissal Of Florida Case Against Heartburn Drug Zantac British drugmaker GSK said on Friday it would seek a dismissal of an ...

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer. "GSK today ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

GSK has always refuted claims that its discontinued heartburn drug had cancer-causing risks, arguing that expert testimonies ...

By Brendan Pierson (Reuters) -GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer ...